文献速递乳腺介入US

超声引导经皮微波消融治疗755个良性乳腺病灶:一项前瞻性多中心研究

Ultrasound-guided percutaneous microwave ablation for 755 benign breast lesions: a prospective multicenter study.
PubMed 文献 · Eur Radiol · 2020-04-30

该前瞻性多中心研究纳入5个中心440例患者共755个经临床病理证实的良性乳腺病灶,评估超声引导经皮微波消融的疗效,并比较国际放射科医生与外科医生的学习曲线。完全消融率达100%,12个月体积缩小率为97.9%,美容满意度良好或优秀者占98.4%。作者认为超声引导经皮微波消融是治疗良性乳腺病灶的有价值技术。

要点

  • 完全消融率达100%,包括45.8%邻近皮肤、胸肌或乳晕的病灶。
  • 中位随访13.7个月,全部病灶12个月体积缩小率为97.9%。
  • 经验增加后单位体积消融时间与能量下降,熟练介入放射科医生掌握技术较快。

关键影像表现/征象

  • 病灶平均最大直径为1.7±0.6 cm。
  • 45.8%的病灶邻近皮肤、胸肌或乳晕。
  • 微波消融前85.7%的病例病灶可触及,消融后55.9%的良性乳腺病灶变为不可触及。

诊断标准与关键数值

  • 完全消融率达100%。
  • 中位随访13.7个月,全部病灶12个月体积缩小率为97.9%。
  • 1.0至2.0 cm病灶12个月体积缩小率为98.6%,≥2.0 cm病灶为96.9%。
  • 美容满意度良好或优秀者占98.4%,微创满意度良好或优秀者占94.5%。

临床应用与阅片要点

  • 作者认为超声引导经皮微波消融是治疗良性乳腺病灶的有价值技术。
  • 作者指出超声引导经皮微波消融有潜力成为治疗良性乳腺病灶的有价值技术。
  • 作者指出熟练的介入放射科医生在掌握该技术方面表现出快速提高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To evaluate the clinical efficacy of microwave ablation (MWA) of benign breast lesions (BBLs) and compare the learning curves of international radiologists (IRs) and surgeons.

METHODS: In total, 440 patients with 755 clinicopathologically confirmed BBLs from 5 centers were prospectively enrolled from February 2014 to July 2018. Technical success, complications, volume reduction ratio (VRR), palpability, and cosmetic satisfaction after ablation were analyzed. In addition, the ablation time (AT) and energy (AE) with the number of procedures were analyzed for learning curve evaluation.

RESULTS: The mean maximum diameter was 1.7 ± 0.6 cm. The complete ablation rate reached 100%, including 45.8% lesions adjacent to the skin, pectoralis, or areola. After a median follow-up of 13.7 months, the 12-month VRR of all lesions was 97.9%, and that for 1.0- to 2.0-cm and ≥ 2.0-cm lesions was 98.6% and 96.9%, respectively. A total of 55.9% of BBLs became nonpalpable (palpable in 85.7% of cases before MWA) by both the clinician and patient. The cosmetic and minimally invasive satisfaction rates were good or excellent in 98.4% and 94.5% of patients, respectively. The median AT/cm3 and AE/cm3 decreased as experience increased. The AE/cm3 of the IR with 5 years of experience was lower than that of the IR with 1 year of experience and the surgeons, while the AT/cm3 of surgeons was comparable with that of the IR with 5 years of experience at relatively mature phase.

CONCLUSIONS: Ultrasound-guided percutaneous MWA is a valuable technique for the treatment of BBLs.

TRIAL REGISTRATION: ClinicalTrials.gov (NCT02860104) KEY POINTS: • Ultrasound-guided percutaneous microwave ablation has the potential to become a valuable technique for the treatment of benign breast lesions. • A skilled interventional radiologist shows a rapid improvement in mastering the technique.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Yang Q, Li H, Chen BH, et al. Ultrasound-guided percutaneous microwave ablation for 755 benign breast lesions: a prospective multicenter study. Eur Radiol. 2020. PMID: 32356159. doi:10.1007/s00330-020-06868-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。